Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study

被引：0
|
作者：
Tang, Huilin
Shaaban, C. Elizabeth
Wu, Yonghui
Magoc, Tanja
Donahoo, William T.
Dekosky, Steven T.
Bian, Jiang
Guo, Jingchuan
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-894-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
894-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1391 - 1395
  • [42] Sodium-glucose Cotransporter-2 Inhibitor Initiation, Risk of Recurrent Gout Flares, and Mortality in Patients with Gout and Type 2 Diabetes: A Population-based Cohort Study
    Wei, Jie
    Choi, Hyon K.
    Dalbeth, Nicola
    Li, Xiaoxiao
    Li, Changjun
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 488 - 490
  • [43] Cardiovascular Risk and Sodium-Glucose Cotransporter 2 Inhibition in Type 2 Diabetes
    Ingelfinger, Julie R.
    Rosen, Clifford J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22): : 2178 - 2179
  • [44] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Genital Mycotic and Urinary Tract Infections: A Population-Based Study of Older Women and Men with Diabetes
    Lega, Iliana C.
    Bronskill, Susan
    Campitelli, Michael A.
    Guan, Jun
    Stall, Nathan M.
    Lam, Kenneth
    Mccarthy, Lisa M.
    Gruneir, Andrea
    Rochon, Paula A.
    DIABETES, 2019, 68
  • [45] Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes
    Ko, Hwa Yeon
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Cho, Young Min
    Kong, Sung Hye
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2023, 6 (09) : E2335797
  • [46] Prescribing Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes-A Continuing Review
    Winters, Ashley
    Lopez, Miguel
    Ray, Gretchen
    Anderson, Joe R.
    DIABETES, 2024, 73
  • [47] Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kristensen, Kasper B.
    Henriksen, Daniel P.
    Hallas, Jesper
    Pottegard, Anton
    Lund, Lars C.
    DIABETOLOGIA, 2021, 64 (07) : 1563 - 1571
  • [48] Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
    Kim, Yoojin
    Babu, Ambika R.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 313 - 327
  • [49] Safety of sodium-glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
    Davidson, Jaime A.
    Sukor, Norlela
    Hew, Fen-Lee
    Mohamed, Mafauzy
    Hussein, Zanariah
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (02) : 167 - 182
  • [50] Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2022, 18 (02): : 198 - 199
12345